Fed. Circ. OKs $12M Fees For Lilly, Elan In IP 'Conspiracy'

The Federal Circuit on Thursday rejected Alzheimer's Institute of America Inc.'s argument that only juries can award attorneys' fees in patent cases, affirming $12 million in fee awards against the company...

Already a subscriber? Click here to view full article